Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The aim of the present study was to examine the influence of memantine, a noncompetitive NMDA
receptor blocker, in depression co-morbid with long term alcohol heavy use comparing to
SSRI-inhibitor, escitalopram. Second goal is to compare their influence to cognitive tasks
and the third goal is to follow up alcohol-use with these two medicines.
Phase:
Phase 4
Details
Lead Sponsor:
Finnish Institute for Health and Welfare National Institute for Health and Welfare, Finland